Announcement
06 Oct 2017
In October 2017, the European Investment Bank (EIB) signed a loan agreement with Amoéba to support its activities related to production capacity, international business and research and development in the area of biological biocide. The loan will be guaranteed by the European Fund for Strategic Investment (EFSI).
Source
Number of interventions
2
2 certainly harmful
0 likely harmful
0 liberalising
Implementation date
06 Oct 2017
Revocation date:
No revocation date
The EIB's loan to Amoéba signed on 6 October 2017 was issued under the European Fund for Strategic Investment (EFSI). The loan has a total value of EUR 20 million (approx. USD 23.5...
On 6 October 2017, the European Investment Bank (EIB) and Amoéba signed two loan agreements having a total value of EUR 20 million (approx. USD 23.5 million). The loans will&n...
See all
This state act is not part of any Thread yet.